Tools
Tools
Fang, W-H, Kumar, S, McDowell, G, Smith, D, Krupinski, J, Olah, P, Al-Baradie, RS, Al-Rukban, MO, Petcu, EB and Slevin, M (2016) Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells. Stem Cells Int, 2016. ISSN 1687-966X
|
Text
Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endotheli.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
The potential use of stem cells as therapeutics in disease has gained momentum over the last few years and recently phase-I clinical trials have shown favourable results in treatment of a small cohort of acute stroke patients. Similarly, they have been used in preclinical models drug-loaded for the effective treatment of solid tumours. Here we have characterized uptake and release of a novel p5-cyclin-dependent kinase 5 (CDK5) inhibitory peptide by mesenchymal stem cells and showed release levels capable of blocking aberrant cyclin-dependent kinase 5 (CDK5) signaling pathways, through phosphorylation of cyclin-dependent kinase 5 (CDK5) and p53. These pathways represent the major acute mechanism stimulating apoptosis after stroke and hence its modulation could benefit patient recovery. This work indicates a potential use for drug-loaded stem cells as delivery vehicles for stroke therapeutics and in addition as anticancer receptacles particularly, if a targeting and/or holding mechanism can be defined.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Hindawi |
| Related URLs: | |
| Date Deposited: | 06 Apr 2020 10:43 |
| Last Modified: | 04 Sep 2021 07:31 |
| DOI or ID number: | 10.1155/2016/2165462 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/12661 |
 |
View Item |